Autoreactive Effector/Memory CD4+ and CD8+ T Cells Infiltrating Grafted and Endogenous Islets in Diabetic NOD Mice Exhibit Similar T Cell Receptor Usage

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Diz, Ramiro ^a   Garland, Alaina ^a   Vincent, Benjamin G ^a   Johnson, Mark C ^a   Spidale, Nicholas ^a   Wang, Bo ^a   Tisch, Roland ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; LYMPH NODE; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET TRANSPLANTATION; SPLEEN;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; GRAFT REJECTION; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPH NODES; MICE; MICE, INBRED NOD; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS;

MUS;

EID: 84871318850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052054     Document Type: Article

References (63)

1. Anderson MS, Bluestone JA, (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485.
2. Bach JF, (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15: 516-542.
3. Bluestone JA, Herold K, Eisenbarth G, (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464: 1293-1300.
4. Tisch R, McDevitt H, (1996) Insulin-dependent diabetes mellitus. Cell 85: 291-297.
5. van Belle TL, Coppieters KT, von Herrath MG, (2011) Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91: 79-118.
6. Delovitch TL, Singh B, (1997) The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7: 727-738.
7. Mallone R, van Endert P, (2008) T cells in the pathogenesis of type 1 diabetes. Curr Diab Rep 8: 101-106.
8. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC, (1994) Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 43: 505-509.
9. Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG, (1988) Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240: 659-662.
10. Wang B, Gonzalez A, Benoist C, Mathis D, (1996) The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 26: 1762-1769.
11. Brooks-Worrell B, Gersuk VH, Greenbaum C, Palmer JP, (2001) Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes. J Immunol 166: 5265-5270.
12. Di Lorenzo TP, Peakman M, Roep BO, (2007) Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 148: 1-16.
13. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, et al. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72.
14. Li L, Wang B, Frelinger JA, Tisch R, (2008) T-cell promiscuity in autoimmune diabetes. Diabetes 57: 2099-2106.
15. Prasad S, Kohm AP, McMahon JS, Luo X, Miller SD (2012) Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. J Autoimmun.
16. Tian J, Gregori S, Adorini L, Kaufman DL, (2001) The frequency of high avidity T cells determines the hierarchy of determinant spreading. J Immunol 166: 7144-7150.
17. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, et al. (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75.
18. Zechel MA, Krawetz MD, Singh B, (1998) Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice. Immunol Rev 164: 111-118.
19. Nakano N, Kikutani H, Nishimoto H, Kishimoto T, (1991) T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med 173: 1091-1097.
20. Toyoda H, Redford A, Magalong D, Chan E, Hosszufalusi N, et al. (1992) In situ islet T cell receptor variable region gene usage in the nonobese diabetic mouse. Immunol Lett 32: 241-245.
21. Waters SH, O'Neil JJ, Melican DT, Appel MC, (1992) Multiple TCR V beta usage by infiltrates of young NOD mouse islets of Langerhans. A polymerase chain reaction analysis. Diabetes 41: 308-312.
22. Candeias S, Katz J, Benoist C, Mathis D, Haskins K, (1991) Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. Proc Natl Acad Sci U S A 88: 6167-6170.
23. DiLorenzo TP, Graser RT, Ono T, Christianson GJ, Chapman HD, et al. (1998) Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc Natl Acad Sci U S A 95: 12538-12543.
24. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B, (1989) Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci U S A 86: 8000-8004.
25. Nagata M, Yoon JW, (1992) Studies on autoimmunity for T-cell-mediated beta-cell destruction. Distinct difference in beta-cell destruction between CD4+ and CD8+ T-cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes 41: 998-1008.
26. Wegmann DR, Norbury-Glaser M, Daniel D, (1994) Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol 24: 1853-1857.
27. Plesner A, Verchere CB, (2011) Advances and challenges in islet transplantation: islet procurement rates and lessons learned from suboptimal islet transplantation. J Transplant 2011: 979527.
28. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, et al. (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54: 2060-2069.
29. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, et al. (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355: 1318-1330.
30. Coulombe M, Gill RG, (2004) The immunobiology of pancreatic islet transplantation. Adv Exp Med Biol 552: 154-169.
31. Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, et al. (1994) Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43: 500-504.
32. Wong CP, Li L, Frelinger JA, Tisch R, (2006) Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice. J Immunol 176: 1637-1644.
33. Jager E, Maeurer M, Hohn H, Karbach J, Jager D, et al. (2000) Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides. Int J Cancer 86: 538-547.
34. Li J, Sze DM, Brown RD, Cowley MJ, Kaplan W, et al. (2010) Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy. Blood 115: 3580-3588.
35. Morice WG, Kimlinger T, Katzmann JA, Lust JA, Heimgartner PJ, et al. (2004) Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques. Am J Clin Pathol 121: 373-383.
36. Pilch H, Hohn H, Freitag K, Neukirch C, Necker A, et al. (2002) Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol 9: 257-266.
37. Berard M, Tough DF, (2002) Qualitative differences between naive and memory T cells. Immunology 106: 127-138.
38. Budd RC, Cerottini JC, MacDonald HR, (1987) Selectively increased production of interferon-gamma by subsets of Lyt-2+ and L3T4+ T cells identified by expression of Pgp-1. J Immunol 138: 3583-3586.
39. DeGrendele HC, Estess P, Siegelman MH, (1997) Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278: 672-675.
40. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, et al. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715.
41. Gerdes J, Schwab U, Lemke H, Stein H, (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20.
42. Vincent BG, Young EF, Buntzman AS, Stevens R, Kepler TB, et al. (2010) Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. J Immunol 184: 4196-4204.
43. Ciupe SM, Devlin BH, Markert ML, Kepler TB, (2009) The dynamics of T-cell receptor repertoire diversity following thymus transplantation for DiGeorge anomaly. PLoS Comput Biol 5: e1000396.
44. He M, Tomfohr JK, Devlin BH, Sarzotti M, Markert ML, et al. (2005) SpA: web-accessible spectratype analysis: data management, statistical analysis and visualization. Bioinformatics 21: 3697-3699.
45. Kepler TB, He M, Tomfohr JK, Devlin BH, Sarzotti M, et al. (2005) Statistical analysis of antigen receptor spectratype data. Bioinformatics 21: 3394-3400.
46. Yang Y, Charlton B, Shimada A, Dal Canto R, Fathman CG, (1996) Monoclonal T cells identified in early NOD islet infiltrates. Immunity 4: 189-194.
47. Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, et al. (2003) Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111: 217-223.
48. Sarukhan A, Gombert JM, Olivi M, Bach JF, Carnaud C, et al. (1994) Anchored polymerase chain reaction based analysis of the V beta repertoire in the non-obese diabetic (NOD) mouse. Eur J Immunol 24: 1750-1756.
49. Sarukhan A, Bedossa P, Garchon HJ, Bach JF, Carnaud C, (1995) Molecular analysis of TCR junctional variability in individual infiltrated islets of non-obese diabetic mice: evidence for the constitution of largely autonomous T cell foci within the same pancreas. Int Immunol 7: 139-146.
50. Liu CP, (2006) Glutamic acid decarboxylase-specific CD4+ regulatory T cells. Ann N Y Acad Sci 1079: 161-170.
51. Komagata Y, Masuko K, Tashiro F, Kato T, Ikuta K, et al. (1996) Clonal prevalence of T cells infiltrating into the pancreas of prediabetic non-obese diabetic mice. Int Immunol 8: 807-814.
52. Han B, Serra P, Yamanouchi J, Amrani A, Elliott JF, et al. (2005) Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest 115: 1879-1887.
53. Galley KA, Danska JS, (1995) Peri-islet infiltrates of young non-obese diabetic mice display restricted TCR beta-chain diversity. J Immunol 154: 2969-2982.
54. Drexler K, Burtles S, Hurtenbach U, (1993) Limited heterogeneity of T-cell receptor V beta gene expression in the early stage of insulitis in NOD mice. Immunol Lett 37: 187-196.
55. Codina-Busqueta E, Scholz E, Munoz-Torres PM, Roura-Mir C, Costa M, et al. (2011) TCR bias of in vivo expanded T cells in pancreatic islets and spleen at the onset in human type 1 diabetes. J Immunol 186: 3787-3797.
56. Baker FJ, Lee M, Chien YH, Davis MM, (2002) Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc Natl Acad Sci U S A 99: 9374-9379.
57. Young EF, Hess PR, Arnold LW, Tisch R, Frelinger JA, (2009) Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct. Autoimmunity 42: 678-691.
58. Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, et al. (1999) Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. J Autoimmun 13: 267-282.
59. Kaufman DL, Tisch R, Sarvetnick N, Chatenoud L, Harrison LC, et al. (2001) Report from the 1st International NOD Mouse T-Cell Workshop and the follow-up mini-workshop. Diabetes 50: 2459-2463.
60. Eisenbarth GS, Kotzin BL, (2003) Enumerating autoreactive T cells in peripheral blood: a big step in diabetes prediction. J Clin Invest 111: 179-181.
61. Li L, He Q, Garland A, Yi Z, Aybar LT, et al. (2009) beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. J Immunol 183: 7585-7591.
62. Lissina A, Ladell K, Skowera A, Clement M, Edwards E, et al. (2009) Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J Immunol Methods 340: 11-24.
63. Liu Z, Cort L, Eberwine R, Herrmann T, Leif JH, et al. (2012) Prevention of type 1 diabetes in the rat with allele-specific anti-T cell receptor antibody. Diabetes 61: 1160-1168.